2.75
price down icon4.18%   -0.12
 
loading

Lantern Pharma Inc Azioni (LTRN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-07-01 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
4.3498
- 4.774 5.8964 5.1796
Operating Income/Loss
-4.3498
- -4.774 -5.8964 -5.1796
Income/Loss From Continuing Operations Before Tax
3.55%
-4.1774
-4.331 -4.5368 -5.8752 -4.5057
Income/Loss From Continuing Operations After Tax
3.55%
-4.1774
-4.331 -4.5368 -5.8752 -4.5057
Net Income/Loss
3.55%
-4.1774
-4.331 -4.5368 -5.8752 -4.5057
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10.83
- 10.78 0.0073 10.76
Diluted Average Shares
10.83
- 10.78 0.0073 10.76
Basic Earnings Per Share
-0.39
- -0.42 -0.54 -0.42
Diluted Earnings Per Share
-0.39
- -0.42 -0.54 -0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$106.92
price down icon 0.46%
$117.67
price up icon 0.84%
$35.01
price down icon 0.26%
$58.83
price down icon 0.32%
ONC ONC
$325.90
price down icon 0.27%
$271.77
price up icon 1.13%
Capitalizzazione:     |  Volume (24 ore):